IR Biosciences Holdings, Inc. (IRBS) – New Company Profile Published

July 3, 2010

By hammersmith

[Source: Official Wire] – IR Biosciences Holdings, Inc. is a development stage biotechnology company. The company, through its wholly-owned subsidiary ImmuneRegen BioSciences, Inc., is engaged in the research and development of potential drug candidate, Homspera and its derivatives, Radilex and Viprovex. The company is headquartered in Scottsdale, Arizona, United States. On May 14, 2009, the company through its wholly owned subsidiary ImmuneRegen BioSciences, entered into a sponsored research agreement with Ted M. Ross, Ph.D., an assistant professor at the University of Pittsburgh’s Center for Vaccine Research.

For more information: IR Biosciences Holdings, Inc. (IRBS) – Financial And Strategic Analysis Review – New Company Profile Published